肝素类抗凝药物作用机制及发展.pptVIP

  • 20
  • 0
  • 约2.92万字
  • 约 85页
  • 2017-06-12 发布于湖北
  • 举报
肝素类抗凝药物作用机制及发展创新

如何理解戊糖的抗栓机制 常用抗凝药物抗凝特性 普通肝素: 有相似的抗Xa与IIa活性 低分子肝素:法安明 克塞 速碧林 抗Xa大于IIa活性 戊糖:磺达肝素钠 只有抗Xa活性 水蛭素类:比伐卢丁 只有抗IIa活性 谢谢 * The manufacturing process for heparin remains much the same today as in the early 1900’s, utilizing a number of extraction and filtration processes, as described in the recipe on this slide. Bivalirudin, however, is manufactured using a modern, synthetic process. The molecule is synthesized using an entirely chemical process, followed by a chromatographic purification and final isolation by lyophilization. * Dr. Irving S. Wright, the first doct

文档评论(0)

1亿VIP精品文档

相关文档